ScinoPharm Taiwan, Ltd. (TPE:1789)
18.45
0.00 (0.00%)
Oct 23, 2025, 1:30 PM CST
ScinoPharm Taiwan Revenue
ScinoPharm Taiwan had revenue of 747.52M TWD in the quarter ending June 30, 2025, a decrease of -1.95%. This brings the company's revenue in the last twelve months to 3.19B, down -6.82% year-over-year. In the year 2024, ScinoPharm Taiwan had annual revenue of 3.41B with 6.91% growth.
Revenue (ttm)
3.19B
Revenue Growth
-6.82%
P/S Ratio
4.57
Revenue / Employee
5.92M
Employees
540
Market Cap
14.59B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.41B | 220.20M | 6.91% |
| Dec 31, 2023 | 3.19B | -77.96M | -2.39% |
| Dec 31, 2022 | 3.26B | 501.71M | 18.16% |
| Dec 31, 2021 | 2.76B | -320.59M | -10.40% |
| Dec 31, 2020 | 3.08B | 190.15M | 6.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Bora Pharmaceuticals Co., LTD. | 21.32B |
| Lotus Pharmaceutical | 19.12B |
| PharmaEssentia | 12.63B |
| Pegavision | 6.67B |
| Sunmax Biotechnology | 1.95B |
| Center Laboratories | 1.60B |
| Oneness Biotech | 112.57M |
| Polaris Group | 64.02M |